{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:25:33Z","timestamp":1768292733313,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jad.2023.01.107","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:22:47Z","timestamp":1675372967000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Serum BDNF levels are involved in the diagnosis and treatment response in patients with PD"],"prefix":"10.1016","volume":"327","author":[{"given":"Ru","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingguang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.01.107_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2023.01.107_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-0327(94)90040-X","article-title":"Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure","volume":"30","author":"Ba\u015fo\u011flu","year":"1994","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.107_bb0015","first-page":"CD010676","article-title":"Antidepressants versus placebo for panic disorder in adults","volume":"4","author":"Bighelli","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2023.01.107_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/gps.4756","article-title":"A re-examination of Montreal cognitive assessment (MoCA) cutoff scores","volume":"33","author":"Carson","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.1290","article-title":"Neurocognitive functioning in individuals at clinical high risk for psychosis: a systematic review and meta-analysis","author":"Catalan","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01178486","article-title":"Fear of fear and the anxiety disorders","volume":"13","author":"Chambless","year":"1989","journal-title":"Cogn. Ther. Res."},{"key":"10.1016\/j.jad.2023.01.107_bb0035","article-title":"Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials","volume":"376","author":"Chawla","year":"2022","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.jad.2023.01.107_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12228","article-title":"Is the Val66Met polymorphism of the brain-derived neurotrophic factor gene associated with panic disorder? A meta-analysis","volume":"9","author":"Chen","year":"2017","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/00332747.2021.1875730","article-title":"Separation anxiety disorder in panic disorder patients with and without comorbid agoraphobia","volume":"84","author":"Dogan","year":"2021","journal-title":"Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0050","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1017\/S0033291720003311","article-title":"The puzzle of quality of life in schizophrenia: putting the pieces together with the FACE-SZ cohort","volume":"52","author":"Ehrminger","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2023.01.107_bb0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/10615806.2011.582949","article-title":"Measurement of anxious traits: a contemporary review and synthesis","volume":"25","author":"Elwood","year":"2012","journal-title":"Anxiety Stress Coping"},{"key":"10.1016\/j.jad.2023.01.107_bb0060","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/pr.114.009126","article-title":"Targeting the modulation of neural circuitry for the treatment of anxiety disorders","volume":"66","author":"Farb","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jad.2023.01.107_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jad.2021.03.084","article-title":"Executive functions in panic disorder: a mini-review","volume":"288","author":"Giomi","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.107_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4321\/S1135-57272014000100007","article-title":"Meta-analysis of group comparison and meta-analysis of reliability generalization of the state-trait anxiety inventory questionnaire (STAI)","volume":"88","author":"Guill\u00e9n-Riquelme","year":"2014","journal-title":"Rev. Esp. Salud Publ."},{"key":"10.1016\/j.jad.2023.01.107_bb0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10571-020-00788-4","article-title":"Effect of escitalopram on serum GDNF and BDNF levels and 5-HT level of brain tissue of obsessive-compulsive disorder rats","volume":"40","author":"Guo","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jad.2023.01.107_bb0080","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpsychires.2022.05.026","article-title":"Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: a meta-analysis","volume":"151","author":"Hao","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.01.107_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/gps.2700","article-title":"Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia","volume":"27","author":"Hendriks","year":"2012","journal-title":"Int. J. Geriatric Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-11-28","article-title":"Depression pathogenesis and treatment: what can we learn from blood mRNA expression?","volume":"11","author":"Hepgul","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2023.01.107_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182212022","article-title":"Anxiety, depression and quality of life-a systematic review of evidence from longitudinal observational studies","volume":"18","author":"Hohls","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2023.01.107_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12877-022-02853-7","article-title":"Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.jad.2023.01.107_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","article-title":"Prevalence of mental disorders in China: a cross-sectional epidemiological study","volume":"6","author":"Huang","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0110","article-title":"Measures of anxiety: state-trait anxiety inventory (STAI), Beck anxiety inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A)","volume":"S467\u2013472","author":"Julian","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jad.2023.01.107_bb0115","first-page":"S23","article-title":"Quality of life: an important dimension in assessing the treatment of depression?","author":"Kennedy","year":"2001","journal-title":"J. Psychiatry Neuroscience"},{"key":"10.1016\/j.jad.2023.01.107_bb0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3934\/genet.2018.3.177","article-title":"Panic disorders: the role of genetics and epigenetics","volume":"5","author":"Kim","year":"2018","journal-title":"AIMS Genet"},{"key":"10.1016\/j.jad.2023.01.107_bb0125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.pnpbp.2005.04.010","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy","volume":"29","author":"Kobayashi","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jad.2007.12.007","article-title":"Beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder","volume":"110","author":"Lee","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.107_bb0135","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00213-018-4950-4","article-title":"Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression","volume":"235","author":"Levy","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2023.01.107_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012422","article-title":"Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder","volume":"97","author":"Lim","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.jad.2023.01.107_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bj.2020.01.001","article-title":"Brain-derived neurotrophic factor and mental disorders","volume":"43","author":"Lin","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.jad.2023.01.107_bb0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jad.2022.07.041","article-title":"Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD","volume":"315","author":"Liu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.107_bb0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1073191115602552","article-title":"The trail making test","volume":"24","author":"Llin\u00e0s-Regl\u00e0","year":"2017","journal-title":"Assessment"},{"key":"10.1016\/j.jad.2023.01.107_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","article-title":"BDNF and synaptic plasticity, cognitive function, and dysfunction","volume":"220","author":"Lu","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jad.2023.01.107_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/erv.2898","article-title":"An exploratory investigation of predictors of outcome in face-to-face and online cognitive-behavioural therapy for bulimia nervosa","volume":"30","author":"Matherne","year":"2022","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.jad.2023.01.107_bb0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-981-32-9705-0_15","article-title":"Anxiety disorders and medical comorbidity: treatment implications","volume":"1191","author":"Meuret","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jad.2023.01.107_bb0175","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/gps.2743","article-title":"Semantic organizational strategy predicts verbal memory and remission rate of geriatric depression","volume":"27","author":"Morimoto","year":"2012","journal-title":"International journal of geriatric psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0180","article-title":"Effects of antidepressant treatment on neurotrophic factors (BDNF and IGF-1) in patients with major depressive disorder (MDD)","volume":"10","author":"Mosio\u0142ek","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jad.2023.01.107_bb0185","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jad.2023.01.107_bb0190","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jad.2014.06.024","article-title":"Neuropsychological impairments in panic disorder: a systematic review","volume":"167","author":"O'Sullivan","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.107_bb0195","first-page":"127","article-title":"BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression","volume":"26","author":"Peng","year":"2018","journal-title":"Discov. Med."},{"key":"10.1016\/j.jad.2023.01.107_bb0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cpr.2015.09.004","article-title":"A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia","volume":"42","author":"Porter","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2023.01.107_bb0205","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fpsyg.2017.00557","article-title":"The stroop color and word test","volume":"8","author":"Scarpina","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2023.01.107_bb0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jad.2017.02.029","article-title":"Restoring function in major depressive disorder: a systematic review","volume":"215","author":"Sheehan","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.107_bb0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.psychres.2018.08.111","article-title":"The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder","volume":"271","author":"Shen","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2023.01.107_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2023.01.107_bb0225","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021414","article-title":"Clinical implications of agoraphobia in patients with panic disorder","volume":"99","author":"Shin","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jad.2023.01.107_bb0230","series-title":"State-Trait Anxiety Inventory and State-Trait Anger Expression Inventory","author":"Spielberger","year":"1994"},{"key":"10.1016\/j.jad.2023.01.107_bb0235","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.psyneuen.2009.07.013","article-title":"Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder","volume":"35","author":"Str\u00f6hle","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2023.01.107_bb0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnint.2013.00055","article-title":"Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis","volume":"7","author":"Suliman","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.jad.2023.01.107_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2004.05.001","article-title":"Predictors for 2-year outcome of major depressive episode","volume":"83","author":"Sz\u00e1d\u00f3czky","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.107_bb0250","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/08039488.2017.1316772","article-title":"Association between personality traits and escitalopram treatment efficacy in panic disorder","volume":"71","author":"V\u00f5hma","year":"2017","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.107_bb0255","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/arclin\/acw100","article-title":"The Chinese version of the brief assessment of cognition in schizophrenia: data of a large-scale mandarin-speaking population","volume":"32","author":"Wang","year":"2017","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.jad.2023.01.107_bb0260","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:41:57Z","timestamp":1759030917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":52,"alternative-id":["S0165032723001258"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.01.107","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum BDNF levels are involved in the diagnosis and treatment response in patients with PD","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.01.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}